Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-004401
Filing Date
2026-01-06
Accepted
2026-01-06 16:05:12
Documents
2
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1528
2 EX-24 tngx-ex24.htm EX-24 13157
  Complete submission text file 0001193125-26-004401.txt   16185
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address
Lee Sung (Reporting) CIK: 0001793200 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39485 | Film No.: 26511401

Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)